Mice carrying loss-of-function mutations in the ATP1A3 gene encoding for α3 have a reduced threshold for induction of epileptiform activity [42] and, in humans, loss-of-function mutations in the ATP1A3 gene are associated with a variety of neurological symptoms and cognitive deficits [12]. Here, ATP1A3 is linked to Cognitive impairment.